Related Experiment Video
Updated: Aug 9, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
Prevention of hepatitis B recurrence after liver transplantation
Wojciech G Polak1, Andrzej Gładysz, Katarzyna Rotter
1Department of Vascular, General and Transplant Surgery, Medical University in Wroclaw, Poland. adalbert@mp.pl
Abstract:
Over the last decade significant improvement in patient and graft survival has been observed after liver transplantation for hepatitis B virus (HBV)-related liver disease, mostly because of efficient prophylaxis against hepatitis B reinfection. This review discusses different approches in prevention of hepatitis B recurrence in liver recipients including new concepts as vaccination against hepatitis B after liver transplantation. Based on available data combined prophylaxis with hepatitis B immunoglobulin (HBIG) and lamivudine is currently recommended prophylaxis for HBV recurrence after liver transplantation.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
